.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Evermore Cannabis Company is stocked at 103 licensed dispensaries across Maryland and Oklahoma, 101 of them in Maryland, with the deepest coverage in Baltimore, Rockville, Silver Spring, Annapolis, and Columbia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Evermore Cannabis Company’s August 2026 mix tilted further toward Flower at 60.09% share despite a -9.26% month-over-month drop and a -4.26% year-over-year decline, while Pre-Roll fell to 12.75% share with steeper contractions of -11.99% MoM and -31.40% YoY. Concentrates held 11.59% share with a +4.58% YoY gain but slipped -12.18% MoM, and Vapor Pens, at 8.77% share, rebounded +14.66% MoM after a -59.28% YoY collapse. Smaller lines were mixed: Edible rose +1.64% MoM but was down -6.41% YoY at 5.73% share, and Capsules edged up +1.07% MoM and +0.97% YoY at 1.07% share. With brand sales down -17.46% YoY and average price down -12.79% YoY to $28.02, the pattern implies price cuts are not fully offsetting volume softness in Flower and Pre-Roll, while the MoM bounce in Vapor Pens provides only partial cushion to the category-led drag.
Positioning in Maryland Flower (rank 8) depends on stabilizing the core as the -9.26% MoM decline in Flower and -11.99% MoM in Pre-Roll compress mix-driven scale, even as Concentrates’ +4.58% YoY and Vapor Pens’ +14.66% MoM suggest selective elasticity. The divergent slopes—deep YoY erosion in Vapor Pens at -59.28% alongside a modest +0.97% YoY in Capsules—indicate the brand is overexposed to categories with higher volatility, and the -12.79% YoY average price drop signals a value repositioning that has not translated into rank gains within Flower (rank 8) or share defense in Pre-Roll (12.75% share). Net, the mix points to a need to re-anchor Flower while leaning into resilient add-ons like Concentrates to diversify revenue density without relying on further price concessions.
Competitive Landscape
Evermore Cannabis Company sits at rank #8 in MD Flower in August 2026, down 3 positions year over year from #5, and 1 position below its May–June 2026 three‑month level at #7; by contrast, SunMed held #1 year over year and remains #1 currently, while Find. surged from #29 to #5 alongside a 525.47% YoY sales gain versus Evermore’s rank slippage. Evermore’s peak at #5 in December 2025 versus today’s #8, combined with competitors like RYTHM steady at #3 with 9.50% YoY growth and District Cannabis fixed at #4 despite a -6.33% YoY sales change, indicates a share reallocation toward movers that climbed multiple ranks. The pattern implies Evermore’s trajectory is one of relative share erosion as faster‑rising brands compress the mid‑tier, requiring either mix shifts or velocity gains to halt further rank descent.
Notable Products
Rainbow Push Pop #4 (3.5g) posted the steepest movement in August 2026 with a -36.7% month-over-month drop while holding rank 6, and Peach RuntZ (3.5g) also declined -16.3% at rank 10, indicating pressure in mid-tier Flower positions. Happy J's- Peach Runtz Pre-Roll 2-Pack (1g) fell -15.8% to rank 3 as Sunset Octane Pre-Roll 2-Pack (1g) inched up +2.0% at rank 5, suggesting Pre-Roll share is consolidating around fewer winners rather than broadening. Two Flower leaders without reported MoM, Deadband #7 x GC5 #12 (3.5g) at rank 1 and Sour Peel (3.5g) at rank 2, bookend a top-10 where seven of the ten SKUs are Flower, concentrating mix and revenue exposure into a single category with rising volatility; Deadband #7 x GC5 #12 (3.5g) alone delivered $157,417. The pattern implies Evermore Cannabis Company is leaning into Flower-led volume while Pre-Rolls provide selective lift, so portfolio risk tilts toward stabilizing flagship Flower while pruning underperforming flavors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
